The Curry International Tuberculosis Center (CITC) proudly announces the online release of 2022 updates to the 3rd edition of its highly acclaimed guide, Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. The updates reflect evolving expert opinion regarding drug-resistant TB care, including the use of shorter treatment regimens. Read about the updates here.
Clinical trial results presented for the first time at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuber
New preventive treatment for children cuts the risk of drug-resistant tuberculosis by more than half
Clinical trial results presented in Paris at the Union World Conference on Lung Health showed that a once-daily dose of a widely available antibiotic over six months cut a child’s risk of developing m
Tuberculosis, which is preventable and curable, has reclaimed the title of the world’s leading infectious disease killer, after being supplanted from its long reign by Covid-19. But worldwide, 40 perc